top of page
COLOURBOX14735021

THE CLICK-ON MEDICAL DEVICE

Catheter-Associated Urinary Tract Infections (CAUTIs) have been reported as the most common hospital-acquired infection worldwide, being responsible for up to 40 % of all hospital-acquired infections.

- We aim to prevent this

katetervector.png

PREVENTING URINARY TRACT INFECTIONS

LATEST NEWS

20.

APR. 2020 

VIOBAC announces collaboration with former regional purchasing manager, Lars Dahl Allerup

Lars Dahl Allerup joins VIOBAC as new co-owner, board-member and strategic advisor. Through his great expertise he will contribute to strategi development, business maturation, go-to-market strategy, value-based sales and more. 

kateter.png

THE PROBLEM

Catheter-associated urinary tract infections (CAUTIs) have been reported as the most common hospital acquired infection in the world being responsible for up to 40% of all hospital infections, with more than 1 million cases per year in the US alone. 

Approximately 25 % of hospitalized patients will undergo urinary catheterization, and nearly 30 % of these will develop CAUTI.

 

The risk of getting a urinary tract infection (UTI) among catherized patients is estimated to be up to 10 % per day, while 100 % are expected to have a UTI after 3 weeks of catherization. 

 

The bacteria are capable of adhering to catheter surfaces in bacterial communities known as biofilm, having greater resistance to the natural immune system of the host as well as being almost resistant to antimicrobials and virtually impossible to eradicate without removing the catheter.

OUR SOLUTION

VIOBAC has invented a solution to the problem.

 

By using a small, unique, patented click-on medical device, we aim to prevent catheter associated infections with simple germicidal UV-technology.

 

This could potentially be the first prophylactic approach with clinical significant effect.

The solution is developed to prevent bacteria from getting into the patients urinary tract system - and will thereby prevent unnecessary urinary tract infections from happening when using a catheter.

COLOURBOX39809251.jpg
TEAM

OUR TEAM

The visions of VIOBAC are driven by two medical doctors with true patient and hospital experience, in collaboration with more than 20 life science professionals including expertise within the fields of microbiology, design- and electromechanics, IP, product purchase and regulatory affairs.

IMG_2578_edited.jpg
COLOURBOX25972775.jpg

NEXT MILESTONES

PATENT

The right IP rights and essential in the world of medical technology.

Our solution has national patent granted and international (PCT) patent pending. 

LABORATORY PoC

The efficacy of our solution has now been proven in professional laboratory settings. We continue to gather firm evidence.

 

R&D

We have partnered up with a major developer of medical equipment in order to optimize our product and regulatory demands.

LATEST AWARDS

VIOBAC has been voted the best university startup in the world within the health category with incorporation of the UN's 17 Sustainable Development Goals, 2019. 

University Startup World Cup

VIOBAC has been chosen as one of the 10 selected participants for NHTT 2019 hosted by Venture Cup

Nordic Health Tech Talents

VIOBAC was named as one of the winners of the 2019 EIT Health Scandinavia Headstart Award.

EIT Health Headstart

PARTNERSHIPS // COLLABORATIONS

prevas_logo-ppt.png
Skærmbillede 2020-11-05 kl. 16.27.10.png
AWA_pdflogga.png
teknologisk-logo.png-sumo.png
DTU-logo.png
KU-logo.jpg

SUND Hub

PikPng.com_string-of-pearls-png_1508355.
44643442_557433204669341_702994643794945
eiteu_logo_0.png

CONTACT US

ADDRESS

500 Terry Francois Street San Francisco, CA 94158

ALTERNATIVELY YOU CAN FILL IN THE FOLLOWING CONTACT FORM:

Thanks for submitting!

TO SPEAK WITH AN AGENT,

PLEASE CALL OR EMAIL US:

CONTACT

GET IN CONTACT

ADDRESS

Lyshøjgårdsvej 47, 4. th
2500 Valby
Denmark

FEEL FREE TO MESSAGE US!

Success! Message has been sent

For any contact please use the contact form or the following information

Email: VIOBAC@outlook.dk

Tel: +45 2611 3220

bottom of page